{"altmetric_id":703282,"counts":{"readers":{"mendeley":116,"citeulike":5,"connotea":0},"facebook":{"unique_users_count":13,"unique_users":["100008089985182","650213733","100004793136546","1425940755","100001265744985","1454510451430719","100000734925754","799504760113084","445882775431414","1489600971290014","135668466471828","689637617723406","489536431117373"],"posts_count":13},"blogs":{"unique_users_count":5,"unique_users":[51455,1416,478,54635,1187],"posts_count":5},"googleplus":{"unique_users_count":1,"unique_users":["Beating Neuropathy"],"posts_count":1},"policy":{"unique_users_count":2,"unique_users":["nap","who"],"posts_count":9},"total":{"posts_count":43},"twitter":{"unique_users_count":13,"unique_users":["vigkap","JorgeHernnRamre","peerrevcongress","StrokeNeurol","h_odakura","Blueprint2HC","FaronFariba","Emma4facs","skipbidder","eturnermd1","JuanGrvas","saltamares","Firefly_fan"],"posts_count":13},"wikipedia":{"unique_users_count":2,"unique_users":["en:482534","en:7806345"],"posts_count":2}},"selected_quotes":["An error. It is not the link (gabapentin) but","Bias and efforts to withhold trial data on Neurontin: Company-Sponsored Trials of Gabapentin for Off-Label Use \u2014","@PDX_Tom Interesting that safety prob increase off-label. Should also raise ?s re lack of efficacy, eg gabapentin.","Dickersin: studied protocols publications about off-label uses of gabapentin #PRC7"],"citation":{"abstract":"There is good evidence of selective outcome reporting in published reports of randomized trials.","abstract_source":"pubmed","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["S. Swaroop Vedula","Lisa Bero","Roberta W. Scherer","Kay Dickersin","Vedula, S. Swaroop","Bero, Lisa","Scherer, Roberta W.","Dickersin, Kay"],"doi":"10.1056\/nejmsa0906126","endpage":"1971","first_seen_on":"2012-04-18T21:27:31+00:00","handles":[],"isbns":[],"issns":["0028-4793","1533-4406"],"issue":"20","journal":"New England Journal of Medicine","last_mentioned_on":1473606848,"links":["http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMsa0906126","http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmsa0906126","http:\/\/dx.doi.org\/10.1056\/NEJMsa0906126","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMsa0906126","http:\/\/content.nejm.org\/cgi\/content\/short\/361\/20\/1963?query=TOC"],"pmid":"19907043","pubdate":"2009-11-12T00:00:00+00:00","publisher":"Mass Med Soc","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1963","subjects":["medicine"],"title":"Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use","type":"article","volume":"361","mendeley_url":"http:\/\/www.mendeley.com\/research\/outcome-reporting-industrysponsored-trials-gabapentin-offlabel"},"altmetric_score":{"score":51.766,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":51.766},"context_for_score":{"all":{"total_number_of_other_articles":8441550,"mean":7.0985200149797,"rank":184525,"this_scored_higher_than_pct":97,"this_scored_higher_than":8257194,"rank_type":"exact","sample_size":8441550,"percentile":97},"similar_age_3m":{"total_number_of_other_articles":93947,"mean":5.3676064760607,"rank":1388,"this_scored_higher_than_pct":98,"this_scored_higher_than":92559,"rank_type":"exact","sample_size":93947,"percentile":98},"this_journal":{"total_number_of_other_articles":20373,"mean":49.48402847045,"rank":3655,"this_scored_higher_than_pct":82,"this_scored_higher_than":16718,"rank_type":"exact","sample_size":20373,"percentile":82},"similar_age_this_journal_3m":{"total_number_of_other_articles":267,"mean":60.811263157895,"rank":66,"this_scored_higher_than_pct":75,"this_scored_higher_than":201,"rank_type":"exact","sample_size":267,"percentile":75}}},"demographics":{"poster_types":{"member_of_the_public":9,"researcher":1,"practitioner":1,"science_communicator":2},"users":{"twitter":{"cohorts":{"Members of the public":9,"Practitioners (doctors, other healthcare professionals)":1,"Science communicators (journalists, bloggers, editors)":2,"Scientists":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":15,"Librarian":1,"Researcher":24,"Student  > Doctoral Student":7,"Student  > Ph. D. Student":16,"Student  > Postgraduate":7,"Student  > Master":8,"Other":19,"Student  > Bachelor":4,"Lecturer":3,"Lecturer > Senior Lecturer":2,"Professor":8},"by_discipline":{"Materials Science":1,"Medicine and Dentistry":86,"Social Sciences":5,"Decision Sciences":1,"Psychology":2,"Mathematics":1,"Unspecified":7,"Neuroscience":1,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":7,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":1,"Philosophy":2}}},"geo":{"twitter":{"DE":1,"JP":1,"GB":2,"ES":1},"mendeley":{"CA":2,"US":6,"JP":1,"GB":5,"ZA":1,"IT":1,"MK":1,"AU":1,"FR":1,"PT":1,"DE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/vigkap\/status\/192722409365835776","citation_ids":[703282],"posted_on":"2012-04-18T21:12:57+00:00","author":{"name":"V","image":"https:\/\/pbs.twimg.com\/profile_images\/2610806418\/y1lswgjeejtffki9pei7_normal.jpeg","description":"Tweets are my opinion not advice","id_on_source":"vigkap","tweeter_id":"308797816","geo":{"lt":null,"ln":null},"followers":359},"tweet_id":"192722409365835776"},{"url":"http:\/\/twitter.com\/JorgeHernnRamre\/status\/435605690556493824","license":"public","citation_ids":[703282],"posted_on":"2014-02-18T02:44:24+00:00","author":{"name":"Jorge H. Ramirez","url":"https:\/\/figshare.com\/authors\/Jorge_H_Ramirez\/587826","image":"https:\/\/pbs.twimg.com\/profile_images\/881989221854130178\/N4eXrb93_normal.jpg","description":"MD, Ph.D, student of penal law","id_on_source":"JorgeHernnRamre","tweeter_id":"513331314","geo":{"lt":51.33962,"ln":12.37129,"country":"DE"},"followers":3369},"tweet_id":"435605690556493824"},{"url":"http:\/\/twitter.com\/peerrevcongress\/status\/377204306363301888","license":"public","citation_ids":[703282],"posted_on":"2013-09-09T22:58:09+00:00","author":{"name":"PeerReviewCongress","url":"http:\/\/www.peerreviewcongress.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1986515208\/PRC_eye_700_normal.jpg","description":"We encourage research into the quality and credibility of peer review and scientific publication to improve conduct, reporting, and dissemination of research","id_on_source":"peerrevcongress","tweeter_id":"539478669","geo":{"lt":null,"ln":null},"followers":1471},"tweet_id":"377204306363301888"},{"url":"https:\/\/twitter.com\/StrokeNeurol\/status\/536516865351094273","license":"datasift","rt":["h_odakura"],"citation_ids":[703282],"posted_on":"2014-11-23T13:49:23+00:00","author":{"name":"\u5e83\u5357\u75c5\u9662 \u8133\u8840\u7ba1\u5185\u79d1@\u533b\u5e2b\u7d76\u8cdb\u52df\u96c6\u4e2d","url":"http:\/\/www.kohnan-sendai.or.jp","image":"https:\/\/pbs.twimg.com\/profile_images\/869753967164538880\/613Y-t-l_normal.jpg","description":"\u4ed9\u53f0\u306e\u8133\u5352\u4e2d\u5c02\u9580\u5185\u79d1\u3067\u3059\uff0e\u8840\u6813\u6eb6\u89e3\/\u7834\u7815\uff0c\u795e\u7d4c\u8d85\u97f3\u6ce2\uff0c\u795e\u7d4c\u5fc3\u7406\u5b66\uff0e\u533b\u5e2b\u7d76\u8cdb\u52df\u96c6\u4e2d.Dept.of Stroke Neurology, Kohnan Hosp, Sendai \/thrombolysis\/thrombectomy \/neurosonology\/behavioral Neurology","id_on_source":"StrokeNeurol","tweeter_id":"243953821","geo":{"lt":null,"ln":null},"followers":1174},"tweet_id":"536516865351094273"},{"url":"https:\/\/twitter.com\/h_odakura\/status\/536514499432296450","license":"datasift","citation_ids":[703282],"posted_on":"2014-11-23T13:39:59+00:00","author":{"name":"\u5c0f\u7530\u5009\u5f18\u5178","url":"http:\/\/dobashin.exblog.jp\/","image":"https:\/\/pbs.twimg.com\/profile_images\/783946122037374976\/sJAHtR6Y_normal.jpg","description":"\u8da3\u5473\u306f\u6c5f\u6238\u7d75\u753b\u3001\u54f2\u5b66\u66f8\u8aad\u307f\u3002JOJO\uff0cPC\u30aa\u30fc\u30c7\u30a3\u30aa\u3001\u30d6\u30ed\u30b0\u66f4\u65b0\u3002\u533b\u8005\u3067\u3042\u308b\u3053\u3068\u3002\u5bb6\u5ead\u533b\u7642\u3001\u5fc3\u623f\u7d30\u52d5\u3002","id_on_source":"h_odakura","tweeter_id":"232780319","geo":{"lt":38.26889,"ln":140.87194,"country":"JP"},"followers":3855},"tweet_id":"536514499432296450"},{"url":"https:\/\/twitter.com\/Blueprint2HC\/status\/551827426427535360","license":"datasift","citation_ids":[703282],"posted_on":"2015-01-04T19:48:05+00:00","author":{"name":"BluePrint2Healthcare","url":"http:\/\/blueprinttohealthcare.com","image":"http:\/\/pbs.twimg.com\/profile_images\/754221118\/croped_header_normal.jpg","description":"Our clinic is very innovative, offering a full circle of health care benefits to our community. Our DOs,PAs, and chiros work together.","id_on_source":"Blueprint2HC","tweeter_id":"73988372","followers":90},"tweet_id":"551827426427535360"},{"url":"https:\/\/twitter.com\/FaronFariba\/status\/625585662754979840","license":"datasift","citation_ids":[703282],"posted_on":"2015-07-27T08:36:59+00:00","author":{"name":"Dr Fariba","url":"http:\/\/Colbetrust.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/621777715012702208\/QlvlnK_x_normal.jpg","description":"Neuroscientist. Global Medicines Regulatory. Founder of the Colb\u00e9 Trust, a patient advocacy charity for medical consumers & participants in clinical trials.","id_on_source":"FaronFariba","tweeter_id":"2781183787","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":261},"tweet_id":"625585662754979840"},{"url":"https:\/\/twitter.com\/Emma4facs\/status\/627547564661993472","license":"datasift","rt":["FaronFariba"],"citation_ids":[703282],"posted_on":"2015-08-01T18:32:53+00:00","author":{"name":"Emma Murphy","url":"http:\/\/emma4facs.uk\/about\/","image":"https:\/\/pbs.twimg.com\/profile_images\/601791778551963648\/LfTvN3I4_normal.jpg","description":"Official Campaign & Trust for AEDs in Pregnancy (FACS) Diagnosed #Epilepsy,Mum of 5 all affected by #facs \ud83e\udd84Award Nominated Blogger \ud83e\udd84 #Valproatecrisis","id_on_source":"Emma4facs","tweeter_id":"277466861","geo":{"lt":53.48095,"ln":-2.23743,"country":"GB"},"followers":2666},"tweet_id":"627547564661993472"},{"url":"http:\/\/twitter.com\/skipbidder\/statuses\/667868855872671745","license":"gnip","citation_ids":[703282],"posted_on":"2015-11-21T00:55:18+00:00","author":{"name":"Leafy Sea Dragon, MD","image":"https:\/\/pbs.twimg.com\/profile_images\/902549443299467264\/EO2do3_U_normal.jpg","description":"Academic hospice doc and geriatrician. I take no pharma money. Whinging lefty. Recovering philosopher. This is now mostly a bitter politics account\u2026","id_on_source":"skipbidder","tweeter_id":"518601549","geo":{"lt":null,"ln":null},"followers":1725},"tweet_id":"667868855872671745"},{"url":"http:\/\/twitter.com\/eturnermd1\/statuses\/684189500331831296","license":"gnip","citation_ids":[703282],"posted_on":"2016-01-05T01:47:43+00:00","author":{"name":"Erick \u0279\u01ddu\u0279n\u22a5","url":"https:\/\/scholar.google.com\/citations?user=im88g8oAAAAJ&hl=en","image":"https:\/\/pbs.twimg.com\/profile_images\/775183956958339072\/oYPd-g5__normal.jpg","description":"Former @US_FDA reviewer. 2017 Sustained #researchparasite\ud83d\udd77 using FDA reviews 2 expose #alternativefacts in clinical trial journal pubs.","id_on_source":"eturnermd1","tweeter_id":"4282193834","geo":{"lt":null,"ln":null},"followers":769},"tweet_id":"684189500331831296"},{"url":"http:\/\/twitter.com\/JuanGrvas\/statuses\/774972926701473794","license":"gnip","citation_ids":[703282],"posted_on":"2016-09-11T14:08:38+00:00","author":{"name":"Juan G\u00e9rvas","url":"http:\/\/www.equipocesca.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2627753335\/IMGP1408_normal.JPG","description":"M\u00e9dico general. General practitioner. Profesor visitante Salud Internacional. Visiting professor International Health","id_on_source":"JuanGrvas","tweeter_id":"833942719","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":11055},"tweet_id":"774972926701473794"},{"url":"http:\/\/twitter.com\/saltamares\/statuses\/774977109630521344","license":"gnip","rt":["JuanGrvas"],"citation_ids":[703282],"posted_on":"2016-09-11T14:25:15+00:00","author":{"name":"saltamares","image":"https:\/\/pbs.twimg.com\/profile_images\/739982225274511360\/963rlHPx_normal.jpg","description":"No comparto necesariamente mis retuits","id_on_source":"saltamares","tweeter_id":"3529733355","geo":{"lt":null,"ln":null},"followers":1032},"tweet_id":"774977109630521344"},{"url":"http:\/\/twitter.com\/Firefly_fan\/statuses\/774989408596553728","license":"gnip","rt":["JuanGrvas"],"citation_ids":[703282],"posted_on":"2016-09-11T15:14:08+00:00","author":{"name":"Marc Casa\u00f1as Escarr\u00e9","image":"https:\/\/pbs.twimg.com\/profile_images\/904680487507066880\/0F7VlOn3_normal.jpg","description":"\"Por lo tanto, si la salud es la ausencia  de anormalidad, la \u00fanica  manera de saber que usted est\u00e1 saludable es  convertirse en un cliente.\" (H. Gilbert Welch)","id_on_source":"Firefly_fan","tweeter_id":"257993878","geo":{"lt":null,"ln":null},"followers":2242},"tweet_id":"774989408596553728"}],"blogs":[{"title":"Science for Sale","url":"http:\/\/healthvsmedicine.blogspot.com\/2009\/11\/science-for-sale.html","license":"public","citation_ids":[703282],"posted_on":"2009-11-12T19:06:00+00:00","summary":"This has gotten a bit of coverage in the corporate media, but they don't do a particularly good job of explaining, so I'll take a shot.  Abstract only for the common folk, I'm afraid, but Dr. Vedula and colleagues, taking advantage of discovery in lawsuits","author":{"name":"Stayin' Alive","url":"http:\/\/healthvsmedicine.blogspot.com","description":""}},{"title":"Suposta falta de etica medica nos estudos com gabapentina","url":"http:\/\/psiquiatriaetoxicodependencia.blogspot.com\/2009\/11\/suposta-falta-de-etica-medica-nos.html","license":"public","citation_ids":[703282],"posted_on":"2009-11-21T21:42:00+00:00","summary":"Documentos internos da compania farmaceutica Pfizer liberados durante processo nos tribunais sugerem que a compania pode ter influenciado os resultados de seus ensaios com a droga gabapentina.O anticonvulsivante gabapentina, vendido sob o nome comercial Ne","author":{"name":"Psiquiatria e Toxicodepend\u00eancia","url":"http:\/\/psiquiatriaetoxicodependencia.blogspot.com\/","description":"Textos sobre psiquiatria, sa\u00fade mental, depend\u00eancia qu\u00edmica e comportamento em busca de uma vis\u00e3o bio-psico-social humanista e integrada da \u00e1rea."}},{"title":"Mag Citrate 4","url":"http:\/\/feedproxy.google.com\/~r\/PallimedAPalliativeMedicineBlog\/~3\/rLyIlSGc5Po\/mag-citrate-4.html","license":"public","citation_ids":[21671422,1626051,2921658,703282,1790013,11979265,207651,1425127],"posted_on":"2009-11-17T03:00:00+00:00","summary":"This will be the last of the Mag Citrate posts for now.  And after reading this monster you'll thank me.  That said, these are all notable papers, each which I hope will be of interest to at least some of our readers: the progno-wonks, the teaching-filists","author":{"name":"Pallimed:  A Hospice and Palliative Medicine Blog","url":"http:\/\/www.pallimed.org\/","description":"Pallimed is a blog of current palliative medicine, hospice, and end-of-life research and news, with a particular focus on publications not from the major palliative care journals.  It is aimed at health care professionals who work with people nearing the end of life."}},{"title":"Open Knowledge Foundation: Update on OpenTrialsFDA: finalist for the Open Science Prize","url":"http:\/\/blog.okfn.org\/2016\/08\/11\/update-on-opentrialsfda-finalist-for-the-open-science-prize\/","license":"public","citation_ids":[703282],"posted_on":"2016-08-11T11:59:00+00:00","summary":"In May, the OpenTrialsFDA team (a collaboration between Erick Turner,&nbsp;Dr. Ben Goldacre&nbsp;and the &nbsp;OpenTrials&nbsp;team at Open Knowledge) was selected as a finalist for the Open Science Prize. This global science competition is focused&nbsp;on","author":{"name":"Planet Code4Lib","url":"http:\/\/planet.code4lib.org","description":"Planet Code4Lib - http:\/\/planet.code4lib.org"}},{"title":"Kaleidoscope 2009 wk 47","url":"http:\/\/laikaspoetnik.wordpress.com\/2009\/11\/19\/kaleidoscope-2009-wk-47\/","license":"public","citation_ids":[1200811,1379399,1540352,703282,112558,10517572,519641],"posted_on":"2009-11-19T00:44:07+00:00","summary":"","author":{"name":"Laika's MedLibLog","url":"http:\/\/laikaspoetnik.wordpress.com\/","description":"A medical librarians exploration of the web 2.0 world and beyond."}}],"wikipedia":[{"title":"Gabapentin","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=444666890#altmetric_citation_49","license":"public","citation_ids":[703282],"posted_on":"2011-08-13T18:17:16+00:00","summary":"Gabapentin (Neurontin) is a medication used as an anticonvulsant and analgesic. It was originally developed to treat epilepsy, and is currently also used to relieve neuropathic pain.","page_url":"http:\/\/en.wikipedia.org\/?curid=482534","wiki_lang":"en","author":{"name":"JaguDorje","url":"http:\/\/en.wikipedia.org\/wiki\/User:JaguDorje"}},{"title":"Reporting bias","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=622600802#altmetric_citation_1","license":"public","citation_ids":[703282],"posted_on":"2014-08-24T13:48:10+00:00","summary":"In epidemiology, reporting bias is defined as &quot;selective revealing or suppression of information&quot; by subjects (for example about past medical history, smoking, sexual experiences).","page_url":"http:\/\/en.wikipedia.org\/?curid=7806345","wiki_lang":"en","author":{"name":"The Collector","url":"http:\/\/en.wikipedia.org\/wiki\/User:The Collector"}}],"facebook":[{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/100008089985182\/posts\/1537528066526845","license":"public","citation_ids":[703282],"posted_on":"2015-01-05T06:32:01+00:00","summary":"www.nejm.org","author":{"name":"Joyce Choppin","url":"https:\/\/www.facebook.com\/100008089985182","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100008089985182\/picture","id_on_source":"100008089985182"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/650213733\/posts\/10153026693063734","license":"public","citation_ids":[703282],"posted_on":"2015-01-06T11:07:28+00:00","summary":"www.nejm.org","author":{"name":"Jolene Oister","url":"https:\/\/www.facebook.com\/650213733","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/650213733\/picture","id_on_source":"650213733"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/100004793136546\/posts\/371157806387321","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T20:38:14+00:00","summary":"www.nejm.org","author":{"name":"Chris Bilsborough","url":"https:\/\/www.facebook.com\/100004793136546","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100004793136546\/picture","id_on_source":"100004793136546"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/1425940755\/posts\/10206000249711750","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T21:08:03+00:00","summary":"www.nejm.org","author":{"name":"Brenda Coats Rich","url":"https:\/\/www.facebook.com\/1425940755","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/1425940755\/picture","id_on_source":"1425940755"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/100001265744985\/posts\/868651603187023","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T21:35:25+00:00","summary":"www.nejm.org","author":{"name":"John Acord","url":"https:\/\/www.facebook.com\/100001265744985","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100001265744985\/picture","id_on_source":"100001265744985"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/1454510451430719\/posts\/1574073212807775","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T22:20:01+00:00","summary":"www.nejm.org","author":{"name":"Peripheral neuropathy help page uk","url":"https:\/\/www.facebook.com\/1454510451430719","facebook_wall_name":"Peripheral neuropathy help page uk","image":"https:\/\/graph.facebook.com\/1454510451430719\/picture","id_on_source":"1454510451430719"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/100000734925754\/posts\/928902100477612","license":"public","citation_ids":[703282],"posted_on":"2015-01-05T12:36:47+00:00","summary":"www.nejm.org","author":{"name":"Michele Isaacson","url":"https:\/\/www.facebook.com\/100000734925754","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100000734925754\/picture","id_on_source":"100000734925754"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/799504760113084\/posts\/850357468361146","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T19:15:01+00:00","summary":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England Journal of Medicine 2009!  There is too much unknown about the effects of this drug! CONCLUSION:\r\nWe identified selective outcome reporting for trials of o","author":{"name":"Dr John Hayes Jr","url":"https:\/\/www.facebook.com\/799504760113084","facebook_wall_name":"Dr John Hayes Jr","image":"https:\/\/graph.facebook.com\/799504760113084\/picture","id_on_source":"799504760113084"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/445882775431414\/posts\/914606178559069","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T19:15:03+00:00","summary":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England Journal of Medicine 2009!  There is too much unknown about the effects of this drug! CONCLUSION:\r\nWe identified selective outcome reporting for trials of o","author":{"name":"Beating Neuropathy","url":"https:\/\/www.facebook.com\/445882775431414","facebook_wall_name":"Beating Neuropathy","image":"https:\/\/graph.facebook.com\/445882775431414\/picture","id_on_source":"445882775431414"}},{"title":"MMS: Error","url":"https:\/\/www.facebook.com\/1489600971290014\/posts\/1525757627674348","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T19:15:03+00:00","summary":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England Journal of Medicine 2009!  There is too much unknown about the effects of this drug! CONCLUSION:\r\nWe identified selective outcome reporting for trials of o","author":{"name":"My Chronic Pain Answers","url":"https:\/\/www.facebook.com\/1489600971290014","facebook_wall_name":"My Chronic Pain Answers","image":"https:\/\/graph.facebook.com\/1489600971290014\/picture","id_on_source":"1489600971290014"}},{"title":"Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use \u2014 NEJM","url":"https:\/\/www.facebook.com\/135668466471828\/posts\/824155767623091","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T19:48:04+00:00","summary":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England Journal of Medicine 2009! There is too much unknown about the effects of this drug! CONCLUSION:\nWe identified selective outcome reporting for trials of off","author":{"name":"Blueprint To Healthcare","url":"https:\/\/www.facebook.com\/135668466471828","facebook_wall_name":"Blueprint To Healthcare","image":"https:\/\/graph.facebook.com\/135668466471828\/picture","id_on_source":"135668466471828"}},{"title":"Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use \u2014 NEJM","url":"https:\/\/www.facebook.com\/689637617723406\/posts\/895098663843966","license":"public","citation_ids":[703282],"posted_on":"2015-01-04T20:08:19+00:00","summary":"www.nejm.org","author":{"name":"Ventura Neuropathy Relief","url":"https:\/\/www.facebook.com\/689637617723406","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/689637617723406\/picture","id_on_source":"689637617723406"}},{"title":"Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use \u2014 NEJM","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1207304112673931&id=489536431117373","license":"public","citation_ids":[703282],"posted_on":"2016-09-10T00:01:52+00:00","summary":"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMsa0906126","author":{"name":"Prevenci\u00f3n Cuaternaria","url":"https:\/\/www.facebook.com\/489536431117373","facebook_wall_name":"Prevenci\u00f3n Cuaternaria","image":"https:\/\/graph.facebook.com\/489536431117373\/picture","id_on_source":"489536431117373"}}],"googleplus":[{"title":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England...","url":"https:\/\/plus.google.com\/103630691386756379063\/posts\/bbir3Q32LLy","citation_ids":[703282],"posted_on":"2015-01-04T19:16:01+00:00","summary":"GABAPENTIN, NEURONTIN use for Neuropathy is considered \"off label\" use. This is from The New England... GABAPENTIN, NEURONTIN use for Neuropathy is considered &quot;off label&quot; use. This is from The New England Journal of Medicine 2009! There is too mu","author":{"name":"Beating Neuropathy","url":"https:\/\/plus.google.com\/+NeuropathyDR","image":"https:\/\/lh4.googleusercontent.com\/-1HvjbJSDoko\/AAAAAAAAAAI\/AAAAAAAAJ28\/PyHuXcSEksc\/photo.jpg?sz=50","id_on_source":"103630691386756379063"}}],"policy":[{"title":"Finding What Works in Health Care: Standards for Systematic Reviews","url":"https:\/\/www.nap.edu\/download\/13059","license":"public","citation_ids":[2411972,15027545,15027546,15027548,15027544,610846,14598047,3848070,15027551,1384088,20479128,1368833,15027552,1369880,14512376,15027553,2376550,15027554,15027555,2072795,15027556,995761,181664,15027557,2173331,4279776,107115,15027558,185532,3294624,14598630,15027559,3401359,8227450,15027561,15027562,15027563,4036237,15027565,15027566,20479130,1591327,117626,2741120,3255900,15027568,5496837,928406,2571920,120669,4148134,232252,14712950,15027570,15027571,1038663,5451419,20479134,4220380,862297,15027572,20479135,15027573,15027574,14717282,173808,5499305,15027575,2179484,15027576,2412926,14728620,15027577,690979,5496703,4633845,3208110,15027579,3448937,16586856,4252308,4315583,11762970,15027581,15027582,483127,3250826,4323634,485437,15027584,4323601,15027585,15027586,2549948,15027588,5712325,1417191,20479137,15027589,441918,20479138,15027590,417585,2574903,15027591,2971123,15027592,3402003,15027594,703282,15027595,15027596,15027597,1369059,9686723,4540793,20479139,1428984,102005,2412752,15027599,3340885,1419704,637999,1262863,1888448,20479140,15027600,8295873,1587861,4702528,828780,15027602,15027603,1340911,1205471,15027605,20475183,4117352,15027606,6701984,3401934,1785847,1205560,15027607,15027608,2183708,2971480,1465330,414786,15027609,15027611,15027612,15027613,15027615,1216031,3401936,560634,9679792,6507334,15027616,14589588,1740266,9023200,8178763,2785224,15027618,15027619,15027620,15027621,2531478,15027622,3401937,15027625,15027626,2361481,819469,981701,1255406,7180900,14712808,20479142,979377,14598114,2971438,5777585,15027630,15027632,1004427,180894,1489064,647085,16694497,15027635,20479143,15027637,1862641,14584962,3634748,4332844,6189890,3244870,1438570,3732569,104952,15027639,101999,3310811,15027643,817124,8858604,20479146,3182544,2334250,15027645,20479147,13695565,1382332,20479148,4292165,15027648,2391103,15027650,15027652,15027654,3636053,16685597,116161,15027656,202980,14598184,2649473,14598199,1130443,1371165,14841679,15027659,413940,15027662,898814,4540343,20479149,15027666,15027668,173905,15027672,486164,15027673,4259594,1124380,15027676,15027677,15027679,1469669,15027681,426084,15027683,1928119,5073574,3104393,3104393,3104393],"posted_on":"2011-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13059\/finding-what-works-in-health-care-standards-for-systematic-reviews","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-0c119358eddfa6cdf0d40cc5c0b0820c0ad5247573e2a1cc4f755bbd92885f73.jpg"}},{"title":"Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk","url":"https:\/\/www.nap.edu\/download\/18998","license":"public","citation_ids":[2905309,2397483,3784821,2576575,879195,7343503,411315,1786196,14482547,5345782,15048867,1439006,1224372,206826,15048871,1383501,14501923,5373702,872676,16669080,1660495,1847271,3667597,125141,15048875,400780,15048876,15048877,1122723,15048878,1445227,176755,115661,1669790,1330731,2175563,1098434,466168,184394,623181,20485026,15048880,828900,3300410,1619268,1586053,1483651,2133504,831608,2781669,1904004,16669081,1911454,1314750,15048881,2668973,751288,2212573,15048882,691243,1660944,120669,15048884,2444816,15048886,126616,1857335,2511579,828780,2640159,2709219,2728126,476520,6507334,1564064,1903879,712050,718882,3247188,483127,14711155,1270425,14584962,4905139,413368,2076573,1161153,1129159,1894762,15048890,15048891,703282,26688469,718219,176764,3838550,4737444,4113016,1365525,15048893,4633438,1335324,14729062,1670488,4890080,15048895,630497,591714,1205811,15048896,4633427,1519183,348759,2027984,15048897,1790094,15048898,2107386,14595409,122066,4147090,15048900,662572,850511,173526,1599725,2154934,580078,1182525,1337055,537088,2350777,691062,15048902,110892,1488966,2174760,2130758,678694,1189094,2064827,387109,3870471,3065114,3065114,3065114],"posted_on":"2015-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/18998\/sharing-clinical-trial-data-maximizing-benefits-minimizing-risk","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-ea6adf3df3cf2dc31f5c0589a053aed2f5ff893ca9b19532aaa2a104f6f20c34.jpg"}},{"title":"Ethical and Scientific Issues in Studying the Safety of Approved Drugs","url":"https:\/\/www.nap.edu\/download\/13219","license":"public","citation_ids":[1247471,15060387,15060388,4570606,14973621,2323607,16688391,2411972,4444573,3306133,1370976,16688393,18260110,2941926,4628155,15060390,15060393,1773348,15060397,117827,2659438,14486666,1034177,1849852,1660751,15060403,206101,15060407,20480249,15060409,3134232,6016351,14486507,126549,4143741,233217,229735,15060413,5792349,5620628,222997,14728907,20480255,3358125,3340087,554142,101999,1825826,15027591,15060422,703282,15060424,120669,20480258,5496748,1621387,3927503,15060428,2249098,15060434,15060442,15060445,4708513,1054183,1610553,117766,481163,15060450,4274490,2709219,15060455,15060458,1487778,6147312,20480267,15060467,15060469,1444717,3943356,15060474,620136,14728901,14501975,5908028,15060478,15060481,15060488,15060490,14713008,15060494,15361573,15060495,200170,421280,5583268,1027557,176856,2840164,173391,455603,381798,3960060,1261624,15015211,4310405,215117,15060507,1371805,15060511,8251697,15048884,15019383,770957,1431469,461472,2115467,109682,3362753,743448,124630,3281266,1514569,450328,173644,210362,173526,6108555,186420,173720,15060523,15060527,581290,2955321,174025,15060534,15060536,18260113,409574,15060539,222506,3810587,3294727,3292063,10775669,3393600,530543,15060548,15060549,15060551,173640,15032177,14499693,18260115,173704,1445055,173736,5682756,1071303,1445114,5772175,1882536,14981506,173535,3554920,5580865,14717282,15060561,15060563,467136,15060565,4695668,15060582,15060582,15060582],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13219\/ethical-and-scientific-issues-in-studying-the-safety-of-approved-drugs","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-0dc64b59a76840ac1ec00f8fc8b48be9471971b913542b1e6043f10b8d3d2042.jpg"}},{"title":"Persisting pain in children package:  WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44540\/49\/9789241548120_Guidelines_rus.pdf","license":"public","citation_ids":[4393877,15844484,10935672,15020388,2460115,15844485,15844486,15844487,4632665,15844488,703282,15844491,15844494,15844496,5046701,3415318,234648,4045868,15844501,15844503,11759482,15844506,15844507,111362,15844509,15844511,15844512,15844513,15844514,15844517,15020185,15844518,15844520,5848398,15844521,15844522,7568081,2948313,15844524,2838350,15844525,15844526,15844527,15844481,15844531,3343992,15844532,3337864,15844535,15844537,15844542,15020355,15844544,15844547,15844549,826486,15844551,1318012,15844553,3150862,3127618,15844556,15844557,15844558,15844561,15844562,15844565,15844569,11905160,4205484,2612582,15844574,15844577,4045882,13685043,2293350,15844580,15844581,1495717,15844584,15844586,15844483,13719395,15844589,13697475,13672675,15844595,4243383,13673627,13652839,13698043,15844602,15844606,4045972,589319,15844609,15844610,1248411,1125972,15844614,15844617,15844622,13766985,15844627],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44540","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-f456a83b569e46bf90a06bdc109c27b6ac652e741473785ff900ebb405a1a0fd.jpg"}},{"title":"Evolution of Translational Omics: Lessons Learned and the Path Forward","url":"https:\/\/www.nap.edu\/download\/13297","license":"public","citation_ids":[766985,16587133,16587134,16587135,6276282,16587136,16587191,16587192,16587194,5824247,16587195,116699,2547179,1447524,3066806,228202,2547178,182454,5104298,779886,2196324,5750725,15022591,210515,165039,1256676,236736,3624111,4738722,595271,16587140,1487816,16583879,1122387,14501646,16699493,16587141,931838,210293,3239597,1983784,16587143,6264262,14501588,149771,14501551,16587144,16587146,16587147,16587148,16587149,16587152,215119,16587156,16587157,2250281,16587159,2828897,20425845,2362634,16587160,14501598,15005493,15028789,16032382,4401422,6078132,16587162,8256720,154251,3639080,16587163,16032411,16198640,16032409,14501565,226405,14716498,16587165,1487817,1439462,3401145,3790780,16587166,15865139,102345,139297,136655,14707411,20479138,14582271,14490534,703282,120669,114950,127010,632275,16587168,4256783,16587169,451345,16587170,5716420,1112828,15022580,20503574,8324462,1374821,5819244,168197,187672,128042,14772513,16587173,16587174,773071,114970,182027,2443893,1353934,20503576,16587176,476520,476376,1447170,1692581,16587177,379483,16587178,1354013,9944759,16587179,1384149,483127,15027659,413940,16587180,1438571,1438570,4104142,117844,817124,16587181,16587183,16587184,483268,16587185,118213,3421828,14476758,15048868,654548,1412422,7707428,1041423,15015102,6015660,1502735,16587186,1234616,1792681,375699,1042076,3959744,16587196,5882524,616878,3284206,200746,376529,20503578,16587198,16587199,16587200,16587201,13545580,16587188,227060,127214,3292063,1390450,421593,1325029,16587137,1447173,5736752,5748384,16587138,16587187,3422424,14501613,2828898,16587189,9708925,1005283,16584749,5882603,5581355,16587190,6107899,2776098,669964,16587202,16587203,16587204,182958,16587205,3419949,3517619,104470,16587206,534146,6077784,5590047,185611,236457,694500,106041,16243276,225324,199019,16587207,17908616,15019360,552376,616463,16587208,526985,238739,238881,187224,16587210,16587211,585555,4818376,16587212,16587213,16587214,16587215,14501536,16587216,14481800,102345,3868931,16587217,6843841,16587135,16587219,4760738,1447524,3063918,3063918,3063918],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13297\/evolution-of-translational-omics-lessons-learned-and-the-path-forward","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-8b6d7db4323beb8044345603dfe071da5c674dc53b54585771de6e865cc5ba48.jpg"}},{"title":"Persisting pain in children package:  WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44540\/35\/9789241548120_Guidelines_ita.pdf","license":"public","citation_ids":[4393877,15844484,10935672,15020388,2460115,15844485,15844486,15844487,4632665,15844488,703282,15844491,15844494,15844496,5046701,3415318,234648,4045868,15844501,15844503,11759482,15844506,15844507,111362,15844509,15844511,15844512,15844513,15844514,15844517,15020185,15844518,15844520,20535974,5848398,15844521,15844522,7568081,2948313,15844524,2838350,15844525,15844526,15844527,15844481,15844531,3343992,15844532,3337864,15844535,15844537,15844542,15020355,1494015,15844544,15844547,15844549,826486,15844551,1318012,15844553,3150862,3127618,15844556,15844557,15844558,15844561,15844562,15844565,15844569,11905160,4205484,2612582,15844574,15844577,4045882,13685043,2293350,15844580,15844581,1495717,15844584,15844586,15844483,13719395,15844589,13697475,13672675,15844595,4243383,13653303,13673627,13698043,15844602,15844606,4045972,2327870,20535998,589319,9976554,15839726,11848134,15844609,15844510],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44540","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-7f1bd9e16b4127fdd10150496bc6e6e850ed9108c87d1440604b4ca6b2eb3cda.jpg"}},{"title":"Persisting pain in children package:  WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44540\/55\/9786177152063_Guidelines_ukr.pdf","license":"public","citation_ids":[4393877,15844484,10935672,15020388,15844485,15844486,15844487,4632665,15844488,703282,15844491,15844494,5046701,3415318,234648,4045868,15844501,15844503,11759482,15844506,15844507,111362,15844509,15844511,15844512,15844513,15844514,15844517,15020185,15844518,15844520,20535974,5848398,15844521,15844522,7568081,2948313,15844524,2838350,15844525,15844526,15844527,15844481,15844531,3343992,15844532,3337864,15844535,15844537,15844542,15020355,1494015,15844544,15844547,15844549,826486,15844551,1318012,15844553,3150862,3127618,15844556,15844557,15844558,15844561,15844562,15844565,15844569,11905160,4205484,2612582,15844574,15844577,4045882,13685043,2293350,15844580,15844581,1495717,15844584,15844586,15844483,13719395,15844589,13697475,13672675,15844595,4243383,13673627,13698043,15844602,15844606,4045972,2327870,20535998,589319,9976554,15839726,11848134,15844609],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44540","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-8472ade13baf9c413b5c267151355a3a5d9cac052b8a9c4a578ab1ed0fd6e08e.jpg"}},{"title":"Persisting pain in children package:  WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44540\/29\/9789608630772_Guidelines_gre.pdf","license":"public","citation_ids":[4393877,15844484,10935672,15020388,2460115,15844485,15844486,15844487,4632665,15844488,703282,15844491,15844494,15844496,5046701,3415318,234648,4045868,15844501,15844503,11759482,15844506,15844507,111362,15844509,15844511,15844512,15844513,15844514,15020185,15844518,15844520,20535974,5848398,15844521,15844522,7568081,2948313,15844524,2838350,15844525,15844526,15844527,15844481,15844531,3343992,15844532,3337864,15844535,15844537,15844542,15020355,1494015,15844544,15844549,826486,15844551,1318012,15844553,3150862,3127618,15844556,15844557,15844558,15844561,15844562,15844565,15844569,11905160,4205484,2612582,15844574,15844577,4045882,13685043,2293350,15844580,15844581,1495717,15844584,15844586,15844483,13719395,15844589,13697475,13672675,15844595,4243383,13653303,13673627,13652839,13698043,15844606,4045972,2327870,20535998,589319,9976554,15839726,11848134,15844609,15844627,15844610,1248411,1125972,15844614,15844617,15844622,13766985,15844510],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44540","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-e08d94661fcdc352c0120310918773276e2911488c80cc97ed51aeea103f796d.jpg"}},{"title":"Conjunto de documentos sobre el dolor persistente en ni\u00f1os: directrices de la OMS sobre el tratamiento farmacol\u00f3gico del dolor persistente en ni\u00f1os con enfermedades m\u00e9dicas","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/77943\/1\/9789243548128_spa.pdf","license":"public","citation_ids":[4393877,15844484,10935672,15020388,2460115,15844485,15844486,15844487,4632665,15844488,703282,15844491,15844494,15844496,5046701,3415318,234648,4045868,15844501,15844503,11759482,15844506,15844507,111362,15844509,15844511,15844512,15844513,15844514,15844517,15020185,15844518,15844520,20535974,5848398,15844521,15844522,7568081,2948313,15844524,2838350,15844525,15844526,15844527,15844481,15844531,3343992,15844532,3337864,15844535,15844537,15844542,15020355,1494015,15844544,15844547,15844549,826486,15844551,1318012,15844553,3150862,3127618,15844483,13672675,2327870,20535998,589319,9976554,15839726,11848134,15844609,15844610,1248411,1125972,15844614,15844617,15844622,11905160,13766985,15844627,15844510,23467259,17154168,22408475,191489,24647898,23393132,24647907,12221998,20689803,24647909,24647912,15844484],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/77943","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-0358edd192c3c87e134cb6f0dd96af885e8b5b33be8a3a874da460e1bf15c929.jpg"}}]}}